Adam Feuerstein at The Street helpfully provides a list of 31 drugs that are awaiting FDA...

|By:, SA News Editor

Adam Feuerstein at The Street helpfully provides a list of 31 drugs that are awaiting FDA approval decisions between now and April, and the relevant dates. The closest D-Day is for Gilead (GILD -1.1%) on Monday next week, when the FDA will decide on the firm's Quad for HIV treatment, which combines four drugs into a single, once-daily pill.